DocSym
β
Searchsearch
Search
(Y52.0) Cardiac-stimulant glycosides and drugs of similar action
More details coming soon
72 652 in individuals diagnosis cardiac-stimulant glycosides and drugs of similar action confirmed
1 277 deaths with diagnosis cardiac-stimulant glycosides and drugs of similar action
2% mortality rate associated with the disease cardiac-stimulant glycosides and drugs of similar action
Diagnosis cardiac-stimulant glycosides and drugs of similar action is diagnosed Women are 16.51% more likely than Men
30 329
Men receive the diagnosis cardiac-stimulant glycosides and drugs of similar action
634 (2.1 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
42 323
Women receive the diagnosis cardiac-stimulant glycosides and drugs of similar action
643 (1.5 %)Died from this diagnosis.
Risk Group for the Disease cardiac-stimulant glycosides and drugs of similar action - Men aged 60-64 and Women aged 75-79
In Men diagnosis is most often set at age 0-5, 10-14, 30-34, 50-64, 70-89
Less common in men the disease occurs at Age 0-1, 5-9, 15-29, 35-49, 65-69, 90-95+Less common in women the disease occurs at Age 0-19, 25-29, 55-59, 95+
In Women diagnosis is most often set at age 20-24, 30-54, 60-94
Disease Features cardiac-stimulant glycosides and drugs of similar action
Absence or low individual and public risk
Cardiac-stimulant glycosides and drugs of similar action - what does this mean
Cardiac-stimulant glycosides and drugs of similar action are drugs that act on the heart to increase its contractility, thereby increasing the output of blood. they work by increasing the availability of calcium ions in the heart muscle, which increases the force of contraction. these drugs can be used to treat heart failure, cardiac arrhythmias, and shock.
What happens during the disease - cardiac-stimulant glycosides and drugs of similar action
Cardiac-stimulant glycosides and drugs of similar action act on the heart by increasing the force of contraction and rate of heart beat. this is achieved by blocking the re-uptake of potassium ions into the cells of the heart, allowing the sodium-potassium pump to be activated, resulting in increased intracellular calcium which further enhances the force of contraction. this action increases the cardiac output and leads to an increased heart rate.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Echocardiogram
- Electrocardiogram (ECG)
- Stress test
- Imaging tests (X-ray, CT scan, or MRI)
- Cardiac catheterization
- Cardiac biopsy
Treatment and Medical Assistance
Main goal of the treatment: To improve the heart's pumping action
- Prescribing cardiac-stimulant glycosides and drugs of similar action
- Monitoring patient's response to drugs
- Adjusting the dosage of the drugs as needed
- Providing lifestyle advice, such as reducing salt intake and exercising regularly
- Monitoring the patient's blood pressure and heart rate
- Providing counselling and support to help the patient cope with the condition
- Referring the patient to a cardiologist for further tests and treatment
11 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Cardiac-stimulant glycosides and drugs of similar action - Prevention
To prevent cardiac-stimulant glycosides and drugs of similar action, it is recommended to avoid taking any medications with these active ingredients unless prescribed by a doctor, as well as to follow a healthy lifestyle with regular exercise and a balanced diet. additionally, it is important to monitor any changes in heart rate or rhythm and to seek medical attention if any symptoms occur.